[1]
M. Wichrowska, J. Kocięcki, and W. Suda, “Switching between aflibercept and ranibizumab in the treatment of refractory exudative age-related macular degeneration”, Ophthatherapy, vol. 8, no. 3, pp. 167-173, Aug. 2021.